Rafferty Asset Management
KURA icon

Rafferty Asset Management’s Kura Oncology KURA Stock Holding History

Rafferty Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$938K Sell
85,486
-48,666
-36% -$459K ﹤0.01% 797
2026
Q1 		$1.09M Sell
134,152
-53,239
-28% -$457K ﹤0.01% 745
2025
Q4 		$1.95M Buy
187,391
+74,169
+66% +$778K 0.01% 651
2025
Q3 		$1M Buy
113,222
+8,112
+8% +$57.8K ﹤0.01% 790
2025
Q2 		$606K Sell
105,110
-25,988
-20% -$159K ﹤0.01% 845
2025
Q1 		$865K Sell
131,098
-14,516
-10% -$113K ﹤0.01% 771
2024
Q4 		$1.27M Buy
145,614
+53,877
+59% +$775K ﹤0.01% 745
2024
Q3 		$1.79M Sell
91,737
-32,848
-26% -$666K 0.01% 671
2024
Q2 		$2.57M Sell
124,585
-186,683
-60% -$3.84M 0.01% 577
2024
Q1 		$6.64M Buy
311,268
+159,994
+106% +$3.11M 0.02% 397
2023
Q4 		$2.18M Sell
151,274
-80,933
-35% -$796K 0.01% 652
2023
Q3 		$2.12M Buy
232,207
+34,574
+17% +$351K 0.01% 598
2023
Q2 		$2.09M Sell
197,633
-76,921
-28% -$910K 0.01% 629
2023
Q1 		$3.36M Sell
274,554
-53,364
-16% -$666K 0.02% 480
2022
Q4 		$4.07M Buy
327,918
+46,004
+16% +$669K 0.03% 420
2022
Q3 		$3.85M Buy
281,914
+186,640
+196% +$2.88M 0.04% 378
2022
Q2 		$1.75M Sell
95,274
-85,809
-47% -$1.23M 0.02% 506
2022
Q1 		$2.91M Sell
181,083
-27,887
-13% -$403K 0.02% 515
2021
Q4 		$2.93M Buy
208,970
+91,758
+78% +$1.49M 0.02% 544
2021
Q3 		$2.19M Buy
117,212
+864
+0.7% +$16.3K 0.02% 615
2021
Q2 		$2.43M Buy
116,348
+3,406
+3% +$84.6K 0.02% 620
2021
Q1 		$3.19M Buy
112,942
+90,544
+404% +$2.86M 0.02% 450
2020
Q4 		$732K Sell
22,398
-6,207
-22% -$218K 0.01% 597
2020
Q3 		$876K Buy
28,605
+16,111
+129% +$356K 0.01% 594
2020
Q2 		$204K Buy
+12,494
New +$180K ﹤0.01% 926
2020
Q1 		– Sell
-21,551
Closed -$296K – 717
2019
Q4 		$296K Sell
21,551
-38,307
-64% -$568K ﹤0.01% 793
2019
Q3 		$908K Buy
59,858
+38,409
+179% +$684K 0.01% 563
2019
Q2 		$422K Sell
21,449
-9,079
-30% -$151K 0.01% 718
2019
Q1 		$506K Buy
+30,528
New +$470K 0.01% 670

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Rafferty Asset Management's KURA Position: Q2 2026 in Review

Rafferty Asset Management reduced its Kura Oncology (KURA) stake by 36% in Q2 2026, selling an estimated $459K and leaving 85,486 shares worth $938K. The position accounts for ﹤0.01% of the portfolio, ranked #797.

Rafferty Asset Management first reported a position in KURA in Q1 2019 and has held it in 29 quarters since. The position peaked at $6.64M in Q1 2024. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Rafferty Asset Management held 85,486 shares of Kura Oncology worth $938K as of Q2 2026.
  • Rafferty Asset Management sold 48,666 Kura Oncology shares in Q2 2026, an estimated $459K.
  • Kura Oncology made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #797 holding.
  • Rafferty Asset Management first reported a position in Kura Oncology in Q1 2019 and has held it in 29 quarters since.
  • Rafferty Asset Management's Kura Oncology position peaked at $6.64M in Q1 2024.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.